Age-related macular degeneration

Age-related macular degeneration (AMD) is a progressive eye disease that damages the macula, the small central part of the retina responsible for sharp, detailed vision. As people age, the cells in this critical region deteriorate, leading to blurred or distorted vision in the center of the visual field, while peripheral vision typically remains intact. There are two main types: dry AMD, characterized by the accumulation of drusen (yellowish deposits), and wet AMD, involving abnormal blood vessel growth beneath the retina. AMD is one of the leading causes of vision loss in people over 50 in developed countries.

AMD appears prominently in ophthalmology, gerontology, and vision research, with significant involvement from molecular biology and genetics research teams. The condition matters because the aging global population means more people are at risk, and vision loss from AMD profoundly impacts quality of life, independence, and mental health. Understanding AMD has also driven broader research into age-related cellular degeneration and inflammation, making it a window into understanding aging itself. Healthcare systems worldwide invest considerable resources in AMD diagnosis, management, and prevention strategies.

AMD develops through a combination of cellular aging, oxidative stress, and inflammation in the retinal pigment epithelium—a layer of cells that nourishes and supports photoreceptors. Think of these supportive cells as caretakers of the retina's light-sensing cells; when they age and become inflamed, they can no longer maintain the photoreceptors effectively, leading to their death and vision loss. Genetic predisposition, smoking, poor diet, and sun exposure all accelerate this process by increasing oxidative damage and inflammatory responses in the eye tissue. In wet AMD, the damaged tissue triggers abnormal blood vessel growth as a failed repair mechanism, which causes further damage through bleeding and fluid leakage.

AMD represents a critical frontier in vision medicine because currently available treatments can only slow progression in some cases, particularly with wet AMD, yet no cure exists. Research into anti-inflammatory drugs, antioxidant therapies, and cell regeneration approaches offers hope for better interventions. Understanding AMD's mechanisms also provides insights into how to maintain retinal health and potentially develop preventive strategies that could preserve vision in millions of aging adults.